| Name | Title | Contact Details |
|---|
Drive DeVilbiss is committed to bringing to market a superior suite of products that focuses on innovation and design while improving the quality of life and promoting the independence for the individuals that use our durable medical equipment. Drive is dedicated to their customers by continually offering the highest quality and most functional products across a broad spectrum of health care needs, products that are a better value and competitively priced delivered by a team of world-class professionals. Drive’s complete line of products enhances the life of each user, from the mobility, bariatric, pressure prevention, self-assist, rehabilitation, pediatric products, to our wheelchairs, sleep surfaces, beds, respiratory equipment, power scooters, patient room equipment, to our electrotherapy devices and personal care products. We are the fastest growing global manufacturers of durable medical equipment; our products are used and distributed throughout North America, Europe, Central America, South America, the Middle East and Asia. Our market spans many verticals including: home healthcare providers, healthcare distributors, retailers, and e-tailers. Our recent expansion includes a new Long-Term Care Division and a new Acute Care Division. These developments are accompanied by the continued growth in the core home health care business. The corporate and distribution offices extend across the United States, Canada, United Kingdom, Germany, Romania, China and Taiwan.
Medical Mobility, Inc. is a Goodlettsville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.
MJM International Corp is a San Juan, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SaluMedica is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.